findmyKOL
Clinical trialNCT01349959CompletedPhase 2Interventional

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

SponsorNational Cancer Institute (NCI)Enrollment58Male Breast CarcinomaRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Triple-Negative Breast Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, United States

  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

  • Unity Hospital

    Fridley, Minnesota, United States

  • Metro Minnesota Community Oncology Research Consortium

    Saint Louis Park, Minnesota, United States

  • University of Pittsburgh Cancer Institute (upci)

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2011
Primary completion
27 Mar 2014
Completion
7 Nov 2023
Last update posted
27 Apr 2025
Registered enrollment
58
Registry id
NCT01349959
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.